FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
62
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

FIT Biotech Oy

Company release May 10, 2017 at 11:00 AM EET

Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

Related to Convertible Note and Warrant Programmes established on September 26, 2016 between the Fit Biotech Oy ("Company") and Bracknor Investment ("Bracknor") the Company's board of directors has today resolved to approve Bracknor's request relating to the funding programme to convert EUR 40,000 worth of Convertible Capital Notes into the Company's K shares.

Due to the conversion of the Convertible Capital Notes, the Company issues 1,043,432 new K shares in the Company to Bracknor with the conversion price of EUR 0.0383 per share.

As a result of the issue of the new K shares in the Company, the total number of shares in the Company will increase to 60,128,019 shares, and the share capital of the Company will be increased by EUR 39,999.97. After the issue of the new K shares in the Company, the Company's shares will be divided in share series as follows: 60,057,555 K shares, 5,229 A shares and 65,235 D shares.

The increase of the share capital and new K shares in the Company will be registered in the Trade Register on or about May 12, 2017 and the new K shares will be admitted to trading on First North Finland on or about May 16, 2017.

FIT BIOTECH OY

Board of Directors

For further information: Chairman of the Board of Directors Rabbe Slätis E-mail: juha.vapaavuori@fitbiotech.com

Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000

About FIT Biotech FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.

DISTRIBUTION: NASDAQ OMX Helsinki Principal media

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lululemon Faces Legal Flare-Up: Investor Suit Unfolds

Updated Category News Views 99

Storm's Brewing for Lululemon It ain't all zen at Lululemon these days. Amidst the yoga mats and stretchy pants, shareholders are unrolling lawsuits like it’s the new Pilates fad. A class action's been slapped on Lululemon Athletica Inc. (NASDAQ: LULU) over alleged investor deception, leaving quite a few with bruised portfolios. The Crux of the Lawsuit So, why is the...

Continue Reading
D-Wave Faces Lawsuit: Promise vs. Reality Shake-up

Updated Category News Views 111

A High-Stakes Drama for D-Wave Quantum Some days on the exchange feel like drinking strong black coffee—sharp and a bit of a jolt. Today, it's D-Wave Quantum that's delivering the punch to investors. With April showers comes the downpour of lawsuits, and D-Wave is getting wet. The company, which had all the thrills of a defining year lined up, has landed slapdab in the...

Continue Reading
How to Assess a True Christian School Experience

Updated Category News Views 82

Making the Right Spiritual Choice for Your Kids Deciding on a Christian school isn't just about academics or facilities—it’s a spiritual journey that shapes your child's worldview and relationship with God. In Kearney, Nebraska, where strong Christian values are prevalent, Anthony Splittgerber of Zion Lutheran School breaks down for HelloNation how faith-based...

Continue Reading
IBM's Sports Tech Challenge Crowns AI Innovator LivXP

Updated Category News Views 12

Pioneering AI for Fan Engagement The big leagues of sports tech are buzzing, as IBM has just announced LivXP as the standout winner of their Sports Tech Startup Prize Challenge at the dynamic Web Summit Lisbon 2026. If there's one thing to remember, it's that this isn't just any accolade. This is a nod from IBM—an institution that's rubbed elbows with the giants of...

Continue Reading
PROYA Skincare Expands to Ulta: A Scientific Ambition

Updated Category News Views 25

A New Chapter for PROYA Bet you didn't see this one coming: a leading Chinese beauty brand, PROYA, is throwing its hat into the North American skincare ring, rolling out its science-backed skincare line nationwide at Ulta Beauty. The same brand that's been big news across Asia is now setting its sights on the U.S. with a stunning array of products that don't just promise...

Continue Reading
Honeywell Aerospace Faces Litigation Amid Stock Decline

Updated Category News Views 166

The Tumbling Honeywell Aerospace Saga Some days, stocks have you feeling like a cat stranded in a tree, and right now, Honeywell Aerospace (NASDAQ:HONA) is very much that cat—with branches breaking beneath it. Investors have been tossed into the fray after the company’s stock nosedived over 23% following ominous earnings and legal revelations. It's a market story...

Continue Reading
Inventive Golf Accessory Offers Fun with Sound Effects

Updated Category News Views 60

Who Knew Golf Clubs Could Sound This Fun? When you think of golf, what comes to mind? Calm fairways, a perfect swing, perhaps the pop of a cork at the clubhouse. But what's this? An accessory promising to shake things up with a bit of character and a splash of sound effects? BUNKER BUDDIES Change the Game There's an inventor out in Highland Heights, Ohio, who’s stirred...

Continue Reading
Nanjing Revives Cultural Legacy of Yangtze River

Updated Category News Views 160

Breathing Life into an Ancient Waterway You'd think the Yangtze River story's as old as the hills—well, you're not wrong. But today, there's a fresh wind blowing down its waters. On November 10, scholars, cultural buffs, and a mixed bag of experts moseyed into Nanjing. They weren't just there to nibble dumplings and wax poetic; they were fixing to shed new light on the...

Continue Reading
HERVolution Welcomes GLP-1 Pioneer for Metabolic Innovations

Updated Category News Views 24

A Legendary Figure Joins HERVolution's Ranks Here’s a story that’ll make the biotech circles sit up and take notice: HERVolution Therapeutics, that spunky outfit in the business of targeting ancient human endogenous retroviruses (HERVs), just landed themselves a major player. Professor Jens Juul Holst, the guy who practically wrote the book on GLP-1, is now part of...

Continue Reading
Target's New Board Member: Sally Grimes Joins the Ranks

Updated Category News Views 81

Grimes Joins Target's Board: A Strategic Move In the world of retail, picking the right players for your team can make all the difference. Target's announcement of Sally Grimes stepping onto their Board of Directors has got my attention, and not just because it shakes things up in a boardroom. Grimes is bringing some heavyweight credentials to the table, and her...

Continue Reading

Top 5 Most Recently Viewed Articles

Nissan's Impact on Renault Group's Q3 Financial Performance

Updated Category News Views 80

Nissan's Impact on Renault Group's Financial Performance Nissan has recently shared its financial outcomes for the second quarter of the fiscal year 2024/2025, covering the period from July 1 to September 30. This fiscal report highlights Nissan’s contribution to the Renault Group’s financial landscape, which is significant given the dynamic automotive market....

Continue Reading
PennyMac Financial Services Set for Upcoming Earnings Release

Updated Category News Views 131

Preparing for PennyMac Financial Services' Earnings Announcement PennyMac Financial Services (PFSI) is set to announce its quarterly earnings soon. Investors are keenly awaiting this update, as it is crucial for understanding potential movements in the stock. Analysts have forecasted that the company will report an earnings per share (EPS) of $3.15, reflecting cautious...

Continue Reading
Concorde International Group Sees Strong Demand in IPO

Updated Category News Views 224

Concorde International Group Capitalizes on Strong IPO Demand In an exciting development for Concorde International Group Ltd. (NASDAQ: CIGL), the company, recognized for its comprehensive security solutions, recently announced a notable advancement in its public offering. With a focus on merging cutting-edge technology with expert manpower, Concorde has strategically...

Continue Reading
How AI and Sponsorship Growth Shape Motorsport's Future

Updated Category News Views 225

The Global Motorsport Market Transformation The motorsport market is on the brink of a substantial transformation, expected to expand by USD 10.79 billion from 2025 to 2029. This growth is fueled by significant sponsorship investments, technological advancements, and a shift towards sustainability. With the introduction of electric vehicles and innovative racing series,...

Continue Reading
Jeffrey W. Gluck: A Leader in Intellectual Property Strategies

Updated Category News Views 130

Jeffrey W. Gluck Recognized Among Top IP Strategists The Philadelphia intellectual property law firm Panitch Schwarze Belisario & Nadel LLP is thrilled to announce that partner Jeffrey W. Gluck, Ph.D., has been named among the IAM Strategy 300 Global Leaders for 2026. This distinction celebrates the foremost intellectual property (IP) strategists globally, providing...

Continue Reading